4SC to Present Biomarker Data for Cancer Drug Resminostat at EHA

News   Jun 18, 2012

 
4SC to Present Biomarker Data for Cancer Drug Resminostat at EHA
 
 
 

RELATED ARTICLES

CRISPR Technology Used to Make Stem Cells

News

In a world first, CRISPR genome editing has been used to reprogram skin cells to function as pluripotent stem cells.

READ MORE

Magnetic MicroRNAs Could Help Treat Incontinence

News

An unlikely combination of magnets and MicroRNAs might be a novel treatment for constipation and incontinence patients.

READ MORE

New Partnership to Provide Bioanalytical and DMPK Services

News

Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE